Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico

The Oncologist
José Carlos Jaime-PérezDavid Gómez-Almaguer

Abstract

Hematopoietic stem cell transplantation (HSCT) in developing countries is cost-limited. Our primary goal was to determine the cost structure for the HSCT program model developed over the last decade at our public university hospital and to assess its clinical outcomes. Adults and children receiving an allogeneic hematopoietic stem cell transplant from January 2010 to February 2011 at our hematology regional reference center were included. Laboratory tests, medical procedures, chemotherapy drugs, other drugs, and hospitalization costs were scrutinized to calculate the total cost for each patient and the median cost for the procedure. Data regarding clinical evolution were incorporated into the analysis. Physician fees are not charged at the institution and therefore were not included. Fifty patients were evaluated over a 1-year period. The total estimated cost for an allogeneic HSCT was $12,504. The two most expensive diseases to allograft were non-Hodgkin lymphoma ($11,760 ± $2,236) for the malignant group and thalassemia ($12,915 ± $5,170) for the nonmalignant group. Acute lymphoblastic leukemia ($11,053 ± 2,817) and acute myeloblastic leukemia ($10,251 ± $1,538) were the most frequent indications for HSCT, with 11 cases each....Continue Reading

References

May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R BarrM Brain
Aug 1, 1997·The American Journal of the Medical Sciences·F M WeeksJ R Wingard
Sep 11, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M van AgthovenC A Uyl-de Groot
Nov 15, 2002·International Journal of Hematology·Ronald D Barr
Nov 15, 2002·International Journal of Hematology·Guillermo J Ruiz-Argüelles
Nov 20, 2002·Bone Marrow Transplantation·P FreyJ N Winter
Feb 27, 2003·Pediatric Transplantation·Ronald D Barr
Jul 5, 2003·International Journal of Hematology·Guillermo J Ruiz-Argüelles, David Gómez-Almaguer
Jan 22, 2004·Archives of Medical Research·Guillermo J Ruiz-Argüelles
Apr 3, 2004·Cancer Treatment Reviews·Alberto RedaelliChris L Pashos
Oct 6, 2004·Expert Opinion on Biological Therapy·Guillermo J Ruiz-Argüelles, David Gómez-Almaguer
Oct 16, 2004·Medicina clínica·José Javier Sánchez-BlancoJosé María Moraleda
May 29, 2007·Bone Marrow Transplantation·O G Cantú-RodríguezD Gómez-Almaguer
Jan 25, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Akiko M SaitoStephanie J Lee
Sep 25, 2008·Bone Marrow Transplantation·F Abdel-RahmanMm Sarhan
Apr 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Navneet S MajhailDaniel J Weisdorf
Aug 21, 2009·Pediatric Blood & Cancer·Navneet S MajhailDaniel J Weisdorf
Nov 26, 2010·The New England Journal of Medicine·Ted A GooleyGeorge B McDonald

❮ Previous
Next ❯

Citations

Jan 23, 2016·American Journal of Hematology·Elias Jabbour, Hagop Kantarjian
Mar 22, 2016·Bone Marrow Transplantation·R P GaleM Pasquini
Sep 28, 2016·Current Clinical Microbiology Reports·Sheena MukkadaMiguela A Caniza
May 25, 2016·Hematology·David Gómez-AlmaguerGuillermo J Ruiz-Argüelles
Oct 4, 2016·The Lancet. Haematology·Guillermo J Ruiz-Argüelles, David P Steensma
Jan 14, 2018·Bone Marrow Transplantation·Amado Kardduss-UruetaGuillermo J Ruiz-Argüelles
Apr 3, 2020·American Journal of Hematology·Elias Jabbour, Hagop Kantarjian
Sep 27, 2020·Hematological Oncology·José Carlos Jaime-PérezDavid Gómez-Almaguer
Jul 29, 2017·International Journal of Rheumatic Diseases·Domingo Garay-MendozaConsuelo Mancías-Guerra
Feb 8, 2018·American Journal of Hematology·Elias Jabbour, Hagop Kantarjian
Jan 23, 2020·Bone Marrow Transplantation·Hani Al-HashmiPanayotis Kaloyannidis
Mar 31, 2021·Transplantation and Cellular Therapy·Perla R Colunga-PedrazaDavid Gómez-Almaguer
May 15, 2021·Bone Marrow Transplantation·Gregorio JaimovichJuliana Martinez Rolón
Aug 12, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WeisdorfJeff Szer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.